
How Kelley Watt Chose an Alternative Cancer Path: Courage, Research, and Defying the Standard Care
Integrative Cancer Solutions with Dr. KarlfeldtShow Notes
On this episode of Integrative Cancer Solutions Dr. Karlfeldt features Kelley Watt as she shares her candid and deeply personal journey after being diagnosed with breast cancer at age 67, having rarely visited doctors in her life. The diagnosis led to immediate recommendations from medical professionals for aggressive treatment, including a double mastectomy, chemotherapy, and radiation—a plan that Kelley found overwhelming, fast-moving, and impersonal. As she recounts, much of the standard approach felt like stepping onto a "chemo conveyor belt," and she describes with clarity and humor how quickly patients are pushed into surgery and systemic therapies, often with little time for research or emotional processing.
Kelley’s skepticism about the standard medical recommendations grew as she encountered discrepancies and perceived a lack of individualized care. She was particularly concerned about the risks of lymphedema and long-lasting side effects like neuropathy, osteoporosis, and organ damage. Frustrated by what felt like a cookie-cutter standard of care and disheartened by her “hostile” label in medical notes for simply refusing chemotherapy, Kelley sought a second opinion and, while offered slightly different protocols, continued to feel alienated by the medical system. She ultimately decided not to pursue the recommended treatments, including surgery and chemotherapy.
Pushed by her need for alternatives, Kelley turned to extensive personal research, digital communities, and advice from friends and family. She radically changed her diet by cutting sugar and carbs, lost significant weight, and discovered stories of cancer patients worldwide who experimented with nutritional supplements like apricot seeds and drugs such as ivermectin and fenbendazole. Despite being unable to find support groups for women who refused chemotherapy, Kelley found encouragement from the online community and relied on her intuition and growing knowledge base to guide her treatment decisions, all while maintaining her active life and work schedule.
Kelley’s story also reveals her reflections on systemic issues within the cancer treatment industry. She shares her belief that the cancer industry is driven largely by fear and profit, citing the financial incentives for oncologists and insurance companies tied to chemotherapy drug prescriptions. She highlights disparities in patient care, problems she perceives in the for-profit healthcare paradigm, and the need for more transparency, patient choice, and information about alternative or natural therapies. Her journey is marked by the challenge of finding safe, affordable, and self-directed solutions, often outside the mainstream system.
The conversation culminates in Kelley’s message of empowerment and the importance of patient agency. She credits her continued well-being, more than a year after diagnosis, to her alternative protocols and her refusal to accept a prognosis dictated solely by standard care. Kelley’s story encourages listeners to seek second opinions, do their own research, connect with others on similar paths, and, above all, advocate for themselves in the healthcare system. Her resolve offers hope and practical advice for those seeking different approaches to cancer care, while emphasizing the necessity for more nuanced, compassionate support for patients facing life-altering medical decisions.
Kelley shares her experience of being diagnosed with breast cancer at 67 and feeling overwhelmed by rapid recommendations for aggressive standard treatments like mastectomy and chemotherapy. She expresses skepticism about the “chemo conveyor belt” of standard care and ultimately refuses chemotherapy, surgery, and radiation in favor of alternative approaches. Through her own research and online communities, Kelley chooses to pursue alternatives like dietary changes, apricot seeds, ivermectin, and fenbendazole, remaining active and symptom-free. Kelley describes her belief that the cancer indu
More from Integrative Cancer Solutions with Dr. Karlfeldt
What if a breast cancer diagnosis is rarely the emergency it feels like, and the time you take next matters most?
Which peptides belong in a cancer protocol, and which ones should wait?
What happens when the surgeon who has spent his career saving other people's lives finally has to save his own? In this episode of Integrative Cancer Solutions, Dr. K sits down with Dr. James C. Wittig, a nationally recognized orthopedic oncologist and sarcoma surgeon and the Founder and CEO of Mandala Medical Group, with roughly 10,000 procedures behind him. He explains why sarcoma in kids and teens so often gets dismissed as a sports injury or growing pains, and how limb-sparing surgery became the standard for most patients. Then he gets personal: thirty years of five-hour nights and eighty-hour weeks that ended in kidney failure and three stents. That experience is why he now brings hypnosis, meditation, neurofeedback and root cause testing like fasting insulin into cancer care. If you or someone you love is facing cancer, this conversation shows what whole-person care can look like from a surgeon who has been on both sides of it. Key Takeaways: Why sarcoma in children and teens gets missed as a sports injury or growing pains How chemotherapy response predicts osteosarcoma survival A sarcoma surgeon's wake-up call: 80-hour weeks, kidney failure and three stents Hypnosis, meditation and neurofeedback for stress and immune health during cancer treatment Fasting insulin, gut health and sugar as root causes in cancer care Schedule a Free 15-Min Cancer/Lyme Consultation at The Karlfeldt Center: 208-338-8902
What if the last piece of your cancer won't go away because it isn't physical at all? In this episode of Integrative Cancer Solutions, Dr. K sits down with Dr. Dana Flavin, a pharmacologist, toxicologist, biochemist and physician with 58 semesters of training behind her and more than 30 years of treating cancer patients around the world. Dana never set out to treat anyone. That changed in 1992, when friends in Ireland asked her to help a woman with advanced cervical cancer, no money and no insurance. Six months later the tumor was gone, and Dana has spent the decades since mapping how foods, nutrients, repurposed drugs and emotions each act on cancer biochemistry. She explains why a single-target drug so often stops working, and how shiitake and maitake mushrooms knock down the same immune-suppressing cells as cimetidine. She covers why a low-methionine, low-sugar, plant-based diet matters, and shares a stage 4 prostate cancer case where PSA dropped from 5,000 to 24.4 in 10 weeks. She also tells the story of a breast cancer patient whose last bit of tumor only cleared after she learned to love herself. If you or someone you love is fighting cancer, or working hard to keep it from coming back, this conversation gives you a lot to take to your care team. Key Takeaways: Why combination cancer therapy works when single-target drugs lead to resistance, from a colon cancer case with liver, lung and lymph metastases How shiitake and maitake mushrooms and cimetidine lower myeloid-derived suppressor cells so the immune system can recover A plant-based, low-methionine, low-sugar diet for cancer, plus cherries, raspberries and organic food Off-label drugs in a stage 4 prostate cancer case: PSA from 5,000 to 24.4 in 10 weeks with itraconazole, ivermectin, mebendazole and low dose naltrexone Emotional healing, forgiveness and staying in remission, and why unresolved hurt can bring cancer back
What if a blue-green algae could help your cells fight cancer the same way your own immune system does? In this episode of Integrative Cancer Solutions, Dr. K talks with Catharine Arnston, PhD, founder of ENERGYbits and author of the upcoming book Love Your Health to Bits with Algae. Catharine has spent years researching spirulina and chlorella, and she walks through why she sees cancer as a metabolic disease, one driven by damaged mitochondria, acidic cells, and the glucose that feeds tumor growth, a process known as the Warburg effect. She breaks down how superoxide dismutase protects your mitochondria from free radical damage, how chlorella clears the toxins that block your cell receptors, and how the blue pigment in spirulina called phycocyanin can trigger cancer cells to self-destruct while leaving healthy cells alone. If you or someone you love is trying to prevent, treat, or recover from cancer, this conversation gives you nutritional tools you can start using today. Key Takeaways: Why cancer is increasingly understood as a metabolic disease driven by the Warburg effect and glucose-fueled cell growth How spirulina's superoxide dismutase (SOD) content protects mitochondria from free radical damage as natural SOD levels decline with age Chlorella's detoxifying effect on cell receptors, and why clearing out cell-blocking toxins matters for nutrient absorption Phycocyanin, the blue pigment unique to spirulina, and its documented anti-angiogenesis effect and role in triggering apoptosis in cancer cells Why cutting simple sugars and carbs and increasing movement lowers the glucose available to feed cancer cells, tracked through the glucose ketone index (GKI)